drugset
drugset / Trial / NCT00595465

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

NCT00595465 ↗

Phase 3 Completed 389 enrolled Valneva Austria GmbH
RandomizedParallel-groupDouble-blindPrevention

Summary

The objective is to demonstrate equivalence of three commercial IC51 batches in terms of geometric mean titers for anti-JEV neutralizing antibody

Timeline

Start
2007-12
Primary completion
2008-02
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator IC51 Vaccine 6 ug Intramuscular

Indications

Japanese encephalitis